Glover v. Merck & Co., Inc.

345 F. Supp. 2d 994, 2004 U.S. Dist. LEXIS 24457, 2004 WL 2677126
CourtDistrict Court, D. Minnesota
DecidedOctober 8, 2004
Docket0:03-cv-05166
StatusPublished
Cited by9 cases

This text of 345 F. Supp. 2d 994 (Glover v. Merck & Co., Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Glover v. Merck & Co., Inc., 345 F. Supp. 2d 994, 2004 U.S. Dist. LEXIS 24457, 2004 WL 2677126 (mnd 2004).

Opinion

ORDER

ROSENBAUM, Chief Judge.

This matter is before the Court on defendant’s motion for judgment on the pleadings. The Honorable Franklin L. Noel, United States Magistrate Judge, issued a Report and Recommendation on August 31, 2004. Both parties made timely objections pursuant to Local Rule 72.1(c)(2).

Based upon a de novo review of the record herein, the Court adopts the Magistrate’s Report and Recommendation. Accordingly, IT IS ORDERED that:

Defendant’s motion for judgment on the pleadings [Docket No. 14] is denied.

REPORT AND RECOMMENDATION

FRANKLIN L. NOEL, United States Magistrate Judge.

THIS MATTER came for a hearing before the undersigned United States Magistrate Judge on July 13, 2004, on Defendant’s Motion for Judgment on the Pleadings [# 14]. The matter was referred to the undersigned for Report and Recommendation pursuant to 28 U.S.C. § 636 and Local Rule 72.1(c). For the reasons which follow, this Court recommends that Defendant’s Motion for Judgment on the Pleadings [# 14] be denied.

I. FACTUAL BACKGROUND

The Plaintiff, Carolyn Glover, is an Illinois resident. (Complaint, ¶ 1). Defendant Merck & Co., Inc., (Merck) is a pharmaceutical company incorporated in New Jersey, with its principal place of business in New Jersey. (Id. at ¶ 2). Merck researches, develops, manufactures, and markets prescription drugs, including the drug Vioxx, an anti-inflammatory analge *996 sic. (Id. at ¶ 5). Ms. Glover brought this products liability diversity case after an injury she alleges was caused by taking Vioxx. The only connection between this case and Minnesota is that Merck sells and distributes its products in the state. Neither party contends that any acts or omissions relating to the facts of this case took place in the State of Minnesota.

In 1999, Ms. Glover obtained a prescription for Vioxx. (Id. at ¶ 7). She took the drug, as prescribed, until October 23, 2000, at which time she was hospitalized for chest pain. (Id.). A few days later, it was determined that Ms. Glover had suffered a deep venous thrombosis in her left leg and pulmonary embolus in the right pulmonary artery, followed by pulmonary infarction. (Id.).

Ms. Glover alleges that Merck knew about adverse health effects related to Vioxx, but concealed the risks in order to compete with comparable products manufactured by other companies. (Id. at ¶ 9-10). A study presented by the European United League Against Rheumatism in June of 2000, showed that Vioxx resulted in a statistically significant increase in hypertension and myocardial infarction. (Id. at ¶ 12). In August of 2001, the Journal of the American Medical Association published a study by the Cleveland Clinic Foundation, showing a risk of a thrombotic cardiovascular event among Vioxx users, such as myocardial infarction, unstable angina, cardiac thrombus, etc. (Id. at ¶ 15). Ms. Glover alleges that she first knew that Vioxx contributed to her injury in April 2003, when her counsel received an expert medical opinion that her condition was caused in whole or part by Vioxx. (Pl.’s Reply to Def.’s Mot. for J. on the Pleadings, 4).

Ms. Glover filed a Complaint in the District of Minnesota on September 3, 2003, nearly three years after her injury. [#1]. She asserts five causes of action: negligence; strict liability; misrepresentation and suppression; breach of warranty; and fraud. Merck has moved for judgment on the pleadings for Counts I, II, III, and V (everything except the claim for breach of warranty). Merck asserts that we should apply Illinois’ two year statute of limitation, under which Ms. Glover’s claims would be time-barred. Ms. Glover argues that the statute of limitations has been satisfied under either Minnesota or Illinois law, and there is no conflict between the laws. Alternatively, she states that if there is a conflict between the laws, the Minnesota statute of limitations applies, and her claims are not time-barred. We conclude that the Minnesota statute of limitations should apply, and the claims do not need to be dismissed.

II. STANDARD OF REVIEW

Merck has moved for judgment on the pleadings pursuant to Federal Rule of Civil Procedure 12(c). On a motion for judgment on the pleadings, a court applies the same standard as in a 12(b)(6) motion for failure to state a claim. See St. Paul Ramsey County Medical Ctr. v. Pennington County, S.D., 857 F.2d 1185, 1187 (8th Cir.1988). The court is to accept as true all of the facts pleaded by the non-moving party and grant all reasonable inferences from the pleadings in favor of the non-moving party. See United States v. Any and All Radio Station Transmission Equipment, 207 F.3d 458, 462 (8th Cir.2000). A court should only grant a motion for judgment on the pleadings where the moving party has clearly established that no material issue of fact remains to be resolved and the party is entitled to judgment as a matter of law. See id.-, Fed. R. Civ. P. 12(c). When considering a motion for judgment on the pleadings, a court should generally ignore materials outside the pleadings, but it may consider materials that are part of the public record. See *997 Porous Media Corp. v. Pall Corp., 186 F.3d 1077, 1079 (8th Cir.1999).

III. LEGAL ANALYSIS

In a diversity case such as.this, federal courts apply the forum state’s choice-of-law rules. See Retail Associates, Inc. v. Macy’s East, Inc., 245 F.3d 694, 697 (8th Cir.2001) (citing Gateway W. Ry. Co. v. Morrison Metalweld Process Corp., 46 F.3d 860, 863 (8th Cir.1995)). We will apply Minnesota choice-of-law principals to determine which state’s statute of limitations to apply, Illinois or Minnesota.

Before applying the choice-of-law analysis, a court must first determine whether or not the laws of the two states conflict. See Jepson v. Gen. Cas. Co. of Wisconsin, 513 N.W.2d 467, 469 (Minn.1994); (citing Myers v. Gov’t Employees Ins. Co., 302 Minn. 359, 225 N.W.2d 238, 241 (1974)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
345 F. Supp. 2d 994, 2004 U.S. Dist. LEXIS 24457, 2004 WL 2677126, Counsel Stack Legal Research, https://law.counselstack.com/opinion/glover-v-merck-co-inc-mnd-2004.